Literature DB >> 2796364

Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations.

K Hisatomi1, T Isomura, T Kawara, M Yamashita, A Hirano, H Yoshida, N Eriguchi, K Kosuga, K Ohishi.   

Abstract

We studied 104 patients after cardiac operations to search for changes in peripheral blood lymphocyte subsets, mitogen responsiveness, and interleukin-2 production. Mononuclear cells obtained from 10 patients with cholecystectomy were examined as control samples. Cultures for phytohemagglutinin and interleukin-2 production were incubated in microtiter plates for 24 hours with cells labeled with tritium thymidine used as target cells. Lymphocyte subsets were measured by using monoclonal antibodies. The results obtained with preoperative blood samples were compared with those from the first, third, and seventh days after operation. In patients having cardiac operations, mitogen responsiveness was low on both the first and the seventh days after operation and interleukin-2 production was markedly depressed (greater than 90% depressed) on the first postoperative day. However, in control samples from patients having cholecystectomy, lymphocyte subsets, mitogen responsiveness, and interleukin-2 production showed no significant changes. Improvement in interleukin-2 production occurred immediately in patients without blood transfusion from random donors and reached normal levels by postoperative day 3. However, interleukin-2 production remained depressed on day 3 in all patients with transfusion from random donors and remained significantly diminished even on day 7 in such patients in New York Heart Association classes III and IV. We conclude that heart operations for which cardiopulmonary bypass is used are associated with depression of cellular immunity, including interleukin-2 production. Furthermore, it appears that both blood transfusion from random donors and the general preoperative condition of the patients contribute to suppression of measures of cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2796364

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Adaptive immunity is severely impaired by open-heart surgery.

Authors:  Tetsuro Sano; Shigeki Morita; Ryuji Tominaga; Munetaka Masuda; Yukihiro Tomita; Toru Yasutsune; Hisataka Yasui
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-05

2.  Interleukin-6 and tumour necrosis factor during cardiopulmonary bypass.

Authors:  K Abe; M Nishimura; T Sakakibara
Journal:  Can J Anaesth       Date:  1994-09       Impact factor: 5.063

3.  Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.

Authors:  C Wenisch; A Bartunek; K Zedtwitz-Liebenstein; M Hiesmayr; B Parschalk; T Pernerstorfer; W Graninger
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  Early IL-2/sIL-2R surge following surgery leads to temporary immune refractoriness.

Authors:  N Lahat; R Shtiller; A Y Zlotnick; G Merin
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

5.  Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy.

Authors:  N Lahat; A Y Zlotnick; R Shtiller; I Bar; G Merin
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

6.  Responses of interleukin-6 and tumor necrosis factor during and after cardiac surgery undergoing cardiopulmonary bypass and pancreatoduodenectomy.

Authors:  Mitsuhiro Nishimura; Kazuo Abe; Tetsuo Sakakibara; Kazuyasu Nakao; Ikuto Yoshiya
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

7.  Simultaneously performed mitral valve replacement and Hartmann's operation for infectious endocarditis from Streptococcus bovis and rectal cancer.

Authors:  Kei Aizawa; Yuichiro Kaminishi; Noribumi Kawamata; Yuki Hirashima; Tsutomu Saito; Yoshio Misawa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-09

8.  Effects of aprotinin on serum interleukin-2 and soluble interleukin-2 receptor during cardiopulmonary bypass.

Authors:  J Luo; D Wang; H Lan; Z Sun
Journal:  J Tongji Med Univ       Date:  2000

9.  Herpes simplex viral pneumonia after coronary artery bypass grafting.

Authors:  Ken-ichi Arata; Ryuzo Sakata; Yoshifumi Iguro; Riichiro Toda; Shun-Ichi Watanabe; Yoshito Eitsuru
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-04

10.  Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery.

Authors:  E Faist; A Markewitz; D Fuchs; S Lang; S Zarius; F W Schildberg; H Wachter; B Reichart
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.